Zeiher Bernhardt G 4

What Happened Bernhardt G. Zeiher, a director of Amylyx Pharmaceuticals, was granted an award on 2026-06-04 covering 24,372 derivative shares. The grant is reported at a $0.00 per-share acquisition price (no cash paid at grant). This is an award (not a sale or market purchase) and does not itself signal a market sale.

Key Details

• Transaction date: June 4, 2026; Form 4 filed June 8, 2026.
• Type: Grant/Award of derivative securities (reported as code "A"); 24,372 shares @ $0.00.
• Vesting: The award vests in full on the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to continuous service (per footnote).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Form 4 was filed four days after the transaction date (filing shows 6/8/2026 for a 6/4/2026 transaction).

Context This filing reports a standard director equity award (likely options or restricted stock units) that vests over time; no shares were sold or purchased on the open market in this transaction. Such grants are common for board compensation and are not direct indicators of immediate buying or selling intentions.